Evaluation of safety, pharmacokinetics, and pharmacodynamics of apixaban in pediatric subjects at risk of venous or arterial thrombotic disorder

• Main Authors: Samira J. Merali (Author), Wonkyung Byon (Author), Yogesh T. Patel (Author), Amira Elsrougy (Author), David Marchisin (Author), Vidya Perera (Author), Weidong Chen (Author), Bing He (Author), Bindu Murthy (Author)
• Format: Book
• Published: Wiley, 2023-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Apixaban is an oral small‐molecule, direct factor Xa (FXa) inhibitor approved in adults for treatment of deep vein thrombosis and pulmonary embolism, and for reducing risk of venous thromboembolism recurrence after initial anticoagulant therapy. This phase I study (NCT01707394) evaluated th...